ADmit Therapeutics appoints Dr. Russell Swerdlow to its Scientific Advisory Board. He is a professor in the Departments of Neurology, Cell Biology and Physiology, and Biochemistry and Molecular Biology at the University of Kansas School of Medicine. He directs the University of Kansas Alzheimer’s Disease Research Center, its Neurodegenerative Disorders Program, and the Heartland Center for Mitochondrial Medicine. He is a recipient of several prestigious Awards like the S. Weir Mitchell Award from the American Academy of Neurology, the Cotzias Award from the American Parkinson’s Disease Association, the Chancellor’s Club Research Award from the University of Kansas, the Dolph Simons Research Achievement Award in the Biomedical Sciences from the University of Kansas, and the Oskar Fischer Prize. He described the "Alzheimer's Disease Mitochondrial Cascade Hypothesis” and it is an honor to have him on board. We are confident that Dr. Swerdlow will significantly contribute to the success of our project. Welcome Russ! #Alzheimersdisease #dementiawareness #EUeic #horizoneu #ADmit #nevertoodifficult #startuphealth #AlzMoonshot
ADmit Therapeutics
Investigación biotecnológica
Esplugues de Llobregat, Barcelona 1989 seguidores
Identification of an early Alzheimer's disease will accelerate the identification of curative drugs
Sobre nosotros
ADmit Therapeutics is a spin off from the Bellvitge Biomedical Research Institute (Barcelona, Spain) focused in the development of an innovative early Alzheimer's disease diagnosis test.
- Sitio web
-
http://www.admit-therapeutics.com
Enlace externo para ADmit Therapeutics
- Sector
- Investigación biotecnológica
- Tamaño de la empresa
- De 2 a 10 empleados
- Sede
- Esplugues de Llobregat, Barcelona
- Tipo
- De financiación privada
- Fundación
- 2017
- Especialidades
- Epigenetics, Next Generation Sequencing, Dementia y Alzheimer's disease
Ubicaciones
-
Principal
c/ Joan XXIII, 10, 08950
Esplugues de Llobregat, Barcelona 08950, ES
Empleados en ADmit Therapeutics
-
Sergio Vernis
-
Santiago Lozano
Tech Transfer Venture Funds Director
-
Miguel A. Viribay
General Manager, Business Division Director, CCO. Life Science, Biotechnology & Diagnostic, Business, Acumen, Leadership, Strategy & Execution 🎯
-
Maite Fibla Gasparin
- Working for a better world - PhD in Economics | Co-Founder & Managing Partner at Ship2B Ventures | Co-Founder at Ship2B Foundation | Investing in…
Actualizaciones
-
We are thrilled to announce that our company has been enrolled in the exciting StartUp Health's Alzheimer's Moonshot Community. Collaboration among different companies is the only way to identify diagnostic and therapeutic solutions that enable personalized medicine in the field of neurodegenerative diseases.
Excited to announce the first 14 companies to join StartUp Health's Alzheimer's Moonshot Community, launched earlier this year with support from Gates Ventures & Alzheimer's Drug Discovery Foundation. I just got off a virtual community kickoff session with our team and founders from all 14 companies (across 6 countries) and am feeling inspired, optimistic, and encouraged about how this group can make orogres, together, in the AD/ADRD space. 💜 A warm welcome 👋 to Marta Barrachina of ADmit Therapeutics, Venkat Shastri of ALZpath Inc., Christy K. Sheehy-Bensinger, PhD of C. Light Technologies, Inc., Luca Giani of Ilios Therapeutics, Ryan Field of Kernel, Nina Kiwit & Manuel Kraus of MindAhead, Paul Campbell & Jen Flexman, PhD, of Moneta Health, Nathan Intrator of Neurosteer, Eliav Shaked & Catherine Bornbaum, PhD, of RetiSpec, Ken Mariash of Sinaptica Therapeutics, Steven Visuri & Ryan Gordon of Stem Pharm, Fernando Johann of TELL Toolkit, Erwin L Roggen of ToxGenSolutions BV (TGS), and Allyson Schrier & William A. Uniowski of Zinnia. Phyllis Ferrell #AlzMoonshot #Alzheimers
-
Our company is proud to announce that we have successfully passed the annual external audit, which demonstrates that the medical device quality management system and its effectiveness is adequately maintained. We are glad to share that, in our tireless effort to pursue the excellence in quality, the scope of our ISO13485:2016 certificate has been expanded to include the manufacturing of our products.
-
We are delighted to announce that Ferran Prat is joining ADmit Therapeutics's Board of Directors as a new Chairman. He holds more than 30 years of experience in the Life Science industry mainly in Diagnostics and Pharmaceutical. He has served as CEO, Corporate Vice President of Marketing, Strategic Alliances and Business Development as well as Chief Commercial Officer and Chief Operations Officer in several companies such as VITRO Group, Werfen, LETI Pharma, DAKO (an Agilent Technologies company) where he has had global responsibility across the whole value chain mainly in headquarters, but also for EMEAI, Americas and Asia Pacific regions where he has been based.
-
Join us this week in the Alzheimer's Drug Discovery Foundation Investigators Day to learn about our breakthrough technology based on novel blood-based biomarkers for the prognosis of AD, and presented by our CEO Marta Barrachina. Visit also our posters during the AD/PD 2024 meeting in Lisbon! (Poster Shift1 0299: Analytical validation of blood mitochondrial methylcytosines for the prognosis of AD dementia progression at MCI stage, and Poster Shift1 0487: Diagnosis of Dementia with Lewy Bodies based on a NGS analysis of blood mitochondrial methylcytosines: a machine learning approach) presented by Marta Blanch Lozano. #nevertoodifficult #ADmit #Alzheimersdisease #dementiawareness #MCI #EUeic #horizoneu
-
ADmit Therapeutics ha compartido esto
Yesterday was an incredible Day 2 at 4YFN – a journey of #health and #innovation! 🎙️ Starting with a Business Matters Podcast on Health Initiatives, led by Elisabet Del Valle from Onalabs Inno-Hub , Sara Toledano from Sycai Medical, and Marta Barrachina from ADmit Therapeutics. 🎤 Engaging pitches from innovative startups: Kompass, HealthFY, Vet2Go, and Oliver, offering unique solutions to current challenges. 💡 Inspiring insights from our #AlumniTalks with Boris Valls Guardiola, Innovation and Healthcare expert, Luis Valente, founder of iLoF, and Talía Bonmatí, founder of Dindog Tech. 👏🏻#EAEMadrid's #DemoDay showcased 7 outstanding startups: De Pasada, Crecemos - Laboratorio de estrategias digitales, Not a Threat (NAT), ARKO, OZZIO, Maiztech and Skintrip. 🏆Jose Luis Santamaria 🍃 finally announced the decision of the jury formed by Aitor Almendros Moreno, Ane de Arino, Andrés Gómez Morón and Jon Etxeberria Ijurra. Big congratulations to NAT for emerging as the winner of EAE Madrid's Demo Day! Join us for Day 3, where we'll unveil the winner of the EAE #ImpactAwards2024! 🚀 #EAEBusinessSchool #EAExperience #WeMakeItHappen #MWC24 #Education #Tech #Entrepreneurship #4YFN24
-
1
-
ADmit Therapeutics would like to highlight the role of women in the STEM on the International Day of Women and Girls in Science. Empowering women is everyone's job and everyone’s responsability. Our team is working together to achieve the Alzheimer’s diagnostic paradigm shift with novel biomarkers. Our slogan is “Never too difficult”!!! #nevertoodifficult #ADmit #InternationalDayofWomenandGirlsinScience #science #Alzheimersdisease #dementiawareness #EUeic #horizoneu
-
ADmit Therapeutics ha compartido esto
🙌🏼 En #EAEBarcelona hemos elegido a las 10 mejores emprendedoras de Cataluña en la segunda edición del #EAETOP10 🥇 Elisabet Del Valle, antigua alumna de EAE Business School, es la ganadora con Onalabs Inno-Hub, que desarrolla, fabrica y comercializa dispositivos médicos que monitorizan la salud a través de la piel y el sudor. Las emprendedoras Marta Barrachina (ADmit Therapeutics), Judit Camargo (Roka Furadada), Noemí Balà Palasí (Aortyx), Talía Bonmatí (Dindog Tech), Katrina Walker (CodeOp), Françoise de Valera (Pack2Earth), Mar Masulli (BitMetrics), ☘ María del Camino Calleja García (YUP), Judith Bayes Cadena (Tramit Smart App), también conforman este TOP 10 del 2023. ¡Muchas felicidades a todas! Lee la noticia completa aquí 👉🏼 https://bit.ly/47Bjxx6 ---------------------------- 🙌🏼 A #EAEBarcelona hem escollit a les 10 millors emprenedores de Catalunya a la segona edició de l'#EAETOP10 🥇 Elisabet Del Valle, antiga alumna d'EAE Business School, és la guanyadora amb Onalabs Inno-Hub, que desenvolupa, fabrica i comercialitza dispositius mèdics que monitoritzen la salut a través de la pell i la suor. Les emprenedores Marta Barrachina (ADmit Therapeutics), Judit Camargo (Roka Furadada), Noemí Balà Palasí (Aortyx), Talía Bonmatí (Dindog Tech), Katrina Walker (CodeOp), Françoise de Valera (Pack2Earth), Mar Masulli (BitMetrics), ☘ María del Camino Calleja García (YUP), Judith Bayes Cadena (Tramit Smart App), també conformen aquest TOP 10 del 2023. Moltes felicitats a totes! Llegeix la noticia completa aquí 👉🏼 https://bit.ly/47Bjxx6
-
5
-
We are seeking a Bioinformatician Junior to join our Bioinformatics and Data Science department #hiring #bioinformatician #NGS
-
Mostramos nuestro agradecimiento a La Vanguardia por hacer hoy difusión de nuestra actividad. #Alzheimersdisease #dementiawareness #EUeic #horizoneu
Páginas similares
Buscar empleos
Financiación
Última ronda
Serie desconocida6.050.698,00 US$